Efficacy of sulfamethoxypyridazine in a murine model of Pneumocystis carinii pneumonia
- PMID: 9559812
- PMCID: PMC105571
- DOI: 10.1128/AAC.42.4.934
Efficacy of sulfamethoxypyridazine in a murine model of Pneumocystis carinii pneumonia
Abstract
Sulfamethoxazole is the component of co-trimoxazole responsible for its efficacy against Pneumocystis carinii pneumonia, but this drug is associated with frequent adverse effects. Sulfamethoxypyridazine is significantly more effective than sulfamethoxazole against a murine model of P. carinii and might be a candidate for testing in infected patients.
References
-
- Anand N. Sulfonamides and sulfones. In: Wolff M, editor. Burger’s medicinal chemistry. New York, N.Y: Wiley Interscience; 1980. pp. 1–40.
-
- Bartlett M S, Queener S F, Durkin M M, Shaw M M, Smith J W. Inoculated mouse model of Pneumocystis carinii infection. Diagn Microbiol Infect Dis. 1992;15:129–134. - PubMed
-
- Cortese L M, Soucy D M, Endy T P. Trimethoprim/sulfamethoxazole desensitization. Ann Pharmacother. 1996;30:184–186. - PubMed
-
- Cribb A E, Lee B L, Trepanier L A, Spielberg S P. Adverse reactions to sulphonamide-trimethoprim antimicrobials: clinical syndromes and pathogenesis. Adverse Drug React Toxicol Rev. 1996;15:9–50. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
